Cinchonine
| Names | |
|---|---|
| IUPAC name
(9S)-Cinchonan-9-ol | |
| Systematic IUPAC name
(S)-[(2R,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol | |
| Identifiers | |
3D model (JSmol) |
|
| 89689 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.003.850 |
| EC Number |
|
| KEGG | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C19H22N2O | |
| Molar mass | 294.39 g/mol |
| Melting point | 260-263 |
| Hazards | |
| GHS labelling: | |
| Warning | |
| H302, H317, H332 | |
| P261, P264, P270, P271, P272, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P321, P330, P333+P313, P363, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Cinchonine is an alkaloid found in Cinchona officinalis. It is used in asymmetric synthesis in organic chemistry. It is a stereoisomer and pseudo-enantiomer of cinchonidine. It was first extracted from cinchona bark by the Portuguese physician Gomez in 1812. Liebig in 1830 made an elemental analysis and found C20H22N2O, close to the correct value of C19H22N2O
It is structurally similar to quinine, an antimalarial drug.
It is a GLP-1 receptor agonist and therefore has potential as a possible treatment for obesity, type 2 diabetes, and non-alcoholic fatty liver disease.